Cyclacel Pharma (CYCC) Tops Q1 EPS by 8c

May 14, 2019 4:21 PM

Cyclacel Pharma (NASDAQ: CYCC) reported Q1 EPS of ($0.12), $0.08 better than the analyst estimate of ($0.20).“We continue to execute ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found